▁Chron 9.2890625
ic 0.54736328125
▁pain 2.765625
▁is 1.1640625
▁still 6.71875
▁considered 3.990234375
▁to 1.9228515625
▁be 0.03277587890625
▁an 2.6796875
▁extreme 7.265625
▁issue 4.02734375
▁among 3.62109375
▁at 9.375
▁least 0.156005859375
▁ 0.390380859375
8 3.474609375
% 2.189453125
▁of 0.12237548828125
▁the 0.5146484375
▁residents 6.63671875
▁of 0.7392578125
▁progress 12.6484375
ive 0.32080078125
▁countries 0.91796875
. 0.63671875
▁The 2.119140625
▁introduction 7.75390625
▁of 0.0309906005859375
▁the 2.359375
▁study 7.3203125
▁describes 7.28125
▁the 0.57568359375
▁apparent 8.9140625
▁link 4.6875
▁between 0.2440185546875
▁pain 2.71484375
▁and 0.294921875
▁dem 7.14453125
oral 3.392578125
ization 0.1217041015625
. 1.046875
▁Chron 4.515625
ic 0.0032444000244140625
▁pain 0.11016845703125
▁is 1.0947265625
▁always 5.60546875
▁accompanied 2.984375
▁by 0.1500244140625
▁negative 4.1484375
▁emot 0.9111328125
ional 1.3955078125
▁experiences 2.984375
▁and 2.080078125
▁blocks 11.3046875
▁a 3.341796875
▁person 0.69140625
’ 0.876953125
s 0.001071929931640625
▁ability 1.3916015625
▁to 0.036834716796875
▁receive 6.84375
▁joy 3.732421875
▁and 1.376953125
▁satisfaction 3.255859375
▁from 0.86572265625
▁life 0.7919921875
. 0.2283935546875
▁The 1.64453125
▁research 2.6875
▁investig 5.40625
ates 0.38720703125
▁the 0.38720703125
▁development 6.15625
▁of 0.1458740234375
▁de 3.841796875
pression 0.45849609375
▁and 1.3544921875
▁anx 1.6201171875
iety 0.0010986328125
▁among 1.6044921875
▁patients 1.48046875
▁receiving 5.83203125
▁ph 5.48046875
arma 3.224609375
ce 0.01218414306640625
ut 6.604194641113281e-05
ical 0.0064239501953125
▁op 4.64453125
io 0.09832763671875
ids 0.440185546875
▁and 2.4921875
▁medical 4.05859375
▁mar 1.75
iju 0.0010881423950195312
ana 4.851818084716797e-05
▁( 2.958984375
MM 1.2978515625
) 2.8984375
▁as 2.44140625
▁severe 9.9921875
▁pain 0.78271484375
kill 2.65625
ers 0.0005288124084472656
. 0.2169189453125
▁It 3.259765625
▁comp 4.98046875
ares 0.008392333984375
▁the 0.59033203125
▁effic 4.30859375
acy 0.0018768310546875
▁of 0.2039794921875
▁pres 6.08984375
cri 1.9091796875
ptions 1.451171875
▁and 1.927734375
▁exam 4.49609375
ines 0.00995635986328125
▁the 0.47314453125
▁possibility 3.95703125
▁of 0.132080078125
▁post 8.203125
- 0.5849609375
tre 1.9677734375
at 0.0017747879028320312
ment 0.004730224609375
▁de 1.6396484375
pression 0.081298828125
. 1.384765625
<0x0A> 0.767578125
There 4.6640625
▁is 1.1904296875
▁currently 5.5546875
▁a 1.0595703125
▁severe 4.9296875
▁lack 1.8564453125
▁of 0.014617919921875
▁information 2.271484375
▁about 1.162109375
▁the 0.47021484375
▁effects 3.1015625
▁of 0.0631103515625
▁op 3.08203125
i 3.7109375
ates 0.011688232421875
. 3.380859375
▁They 4.52734375
▁manage 8.40625
▁pain 3.39453125
▁successfully 5.81640625
, 0.97412109375
▁but 0.234375
▁the 2.478515625
▁past 9.0546875
▁few 2.25
▁dec 1.248046875
ades 0.0006232261657714844
▁indicated 7.015625
▁the 1.73828125
▁growing 3.603515625
▁concern 3.3828125
▁regarding 2.716796875
▁op 2.5546875
iate 1.0869140625
▁ab 1.5830078125
use 0.01509857177734375
▁in 3.8359375
▁forms 8.859375
▁of 0.25048828125
▁over 3.283203125
d 0.1043701171875
ose 0.3251953125
▁and 0.701171875
▁add 0.701171875
iction 0.01934814453125
. 0.1365966796875
▁A 4.0390625
▁more 4.79296875
▁manage 7.921875
able 0.0005059242248535156
▁and 2.11328125
▁sa 2.064453125
fer 0.000156402587890625
▁alternative 1.3193359375
▁might 5.10546875
▁be 0.11883544921875
▁medical 1.5791015625
▁mar 0.1561279296875
iju 0.0006966590881347656
ana 9.66787338256836e-05
. 0.95166015625
▁However 3.326171875
, 0.00254058837890625
▁the 1.6845703125
▁legal 3.953125
▁status 1.1416015625
▁and 3.126953125
▁novel 9.84375
ty 0.133056640625
▁of 0.1466064453125
▁this 2.33203125
▁drug 1.37890625
▁do 4.359375
▁not 0.0124359130859375
▁allow 0.69873046875
▁finding 6.921875
▁a 2.380859375
▁large 2.556640625
▁number 0.78515625
▁of 0.0020751953125
▁studies 1.2890625
▁on 1.767578125
▁its 0.7998046875
▁effect 2.37109375
iveness 0.1767578125
. 0.64306640625
▁Specifically 8.9765625
, 0.04681396484375
▁it 2.630859375
▁concerns 5.05078125
▁the 0.81689453125
▁emot 6.55859375
ional 0.01873779296875
▁condition 4.6015625
▁of 0.2186279296875
▁patients 0.67626953125
▁experien 5.25
cing 1.6450881958007812e-05
▁chron 0.80908203125
ic 0.0003542900085449219
▁pain 0.050323486328125
. 0.437255859375
▁This 2.923828125
▁research 1.8896484375
▁paper 4.05078125
▁a 1.8330078125
ims 0.0005173683166503906
▁to 0.11553955078125
▁analyze 3.291015625
▁levels 9.9296875
▁of 0.0205535888671875
▁de 0.494140625
pression 0.023956298828125
▁and 0.1829833984375
▁anx 0.024078369140625
iety 0.0004162788391113281
▁among 0.74365234375
▁people 2.482421875
▁receiving 2.236328125
▁ther 6.6171875
apy 0.1036376953125
▁by 4.546875
▁comparing 8.8515625
▁the 1.5341796875
▁effects 2.150390625
▁of 0.023895263671875
▁ph 2.94921875
arma 0.0309295654296875
ce 0.0031757354736328125
ut 9.85860824584961e-05
ical 0.00360107421875
▁op 0.11798095703125
io 0.61865234375
ids 0.0305633544921875
▁and 0.242919921875
▁MM 0.476806640625
. 0.252685546875
<0x0A> 0.449951171875
The 0.74853515625
▁data 4.6796875
▁was 1.9482421875
▁collected 0.75390625
▁and 3.861328125
▁analyz 0.65185546875
ed 0.0008358955383300781
▁in 2.240234375
▁the 1.416015625
▁form 2.322265625
▁of 0.0064697265625
▁a 0.80322265625
▁study 3.888671875
. 1.9169921875
<0x0A> 4.6640625
The 0.73291015625
▁most 6.609375
▁reve 7.4453125
aling 0.0009937286376953125
▁and 3.080078125
▁inclus 9.0546875
ive 0.0018749237060546875
▁type 4.84375
▁of 0.057159423828125
▁study 1.7373046875
▁is 1.1787109375
▁the 1.2265625
▁one 3.25
▁that 1.0830078125
▁contains 4.13671875
▁direct 5.99609375
▁responses 6.7109375
▁from 0.615234375
▁a 2.6953125
▁large 1.25
▁number 0.5517578125
▁of 0.0027751922607421875
▁participants 1.072265625
. 0.283447265625
<0x0A> 2.826171875
The 0.8759765625
▁analysis 4.73828125
▁of 0.984375
▁any 7.015625
▁human 6.9453125
▁reaction 4.42578125
▁has 5.0390625
▁a 1.9189453125
▁high 2.84375
▁potential 3.2109375
▁of 1.4384765625
▁subject 2.962890625
iveness 3.470703125
▁and 1.44921875
▁bias 1.6943359375
, 2.087890625
▁especially 2.58203125
▁regarding 4.19921875
▁people 5.125
▁in 4.13671875
▁severe 2.84375
▁pain 0.54736328125
▁and 2.6484375
▁un 5.875
stable 0.98291015625
▁emot 0.6904296875
ional 0.063232421875
▁condition 1.5625
. 0.065185546875
▁Perhaps 9.78125
▁some 6.2890625
▁patients 2.544921875
▁tend 4.69140625
▁to 0.00843048095703125
▁ex 1.8916015625
agger 0.01084136962890625
ate 0.0017108917236328125
▁their 1.0244140625
▁de 3.302734375
press 1.9443359375
ive 0.07470703125
▁state 2.091796875
▁or 2.224609375
▁vice 5.1171875
▁vers 0.038726806640625
a 7.045269012451172e-05
, 1.0361328125
▁de 7.10546875
- 2.701171875
emph 0.431884765625
as 0.0035076141357421875
ize 0.053131103515625
▁serious 7.01953125
▁difficulties 5.61328125
. 0.6494140625
▁Because 6.65234375
▁the 3.287109375
▁survey 4.70703125
▁responses 6.25
▁were 1.5615234375
▁thoroughly 8.9140625
▁anonymous 2.5625
, 0.2027587890625
▁the 1.08203125
▁research 1.33203125
ers 0.67138671875
▁were 2.1796875
▁unable 3.791015625
▁to 0.0020313262939453125
▁carefully 8.0078125
▁analyze 2.4609375
▁each 2.3984375
▁patient 2.9140625
’ 0.5068359375
s 0.0010929107666015625
▁reaction 3.908203125
▁and 1.5634765625
▁compare 3.791015625
▁it 0.81591796875
▁to 0.59326171875
▁the 0.97314453125
▁actual 4.31640625
▁states 8.4375
▁of 0.5234375
▁condition 6.81640625
. 0.33544921875
▁More 6.87109375
▁accurate 3.2421875
▁answers 4.9609375
▁could 1.7255859375
▁be 0.5556640625
▁obtained 1.0751953125
▁by 1.462890625
▁professional 5.4609375
▁psych 1.2548828125
olog 0.327880859375
ists 0.001567840576171875
▁via 6.99609375
▁personal 2.78125
▁communication 4.453125
▁and 2.28125
▁behavior 6.265625
al 0.314453125
▁analysis 2.00390625
. 0.28076171875
▁However 2.615234375
, 0.0011491775512695312
▁this 1.6201171875
▁method 2.353515625
▁of 2.375
▁research 1.7041015625
▁is 1.0947265625
▁way 5.83203125
▁more 1.1865234375
▁resource 4.58203125
- 0.33544921875
int 1.4599609375
ensive 0.025604248046875
▁and 0.453857421875
▁energy 11.0625
- 0.1043701171875
consum 0.427734375
ing 0.0021762847900390625
. 0.724609375
<0x0A> 0.5869140625
Part 5.8203125
icip 0.271728515625
ants 0.163818359375
▁were 1.2109375
▁rec 3.205078125
ru 0.0008740425109863281
ited 5.626678466796875e-05
▁for 4.06640625
▁six 7.66015625
▁months 0.33447265625
▁at 3.705078125
▁two 2.548828125
▁major 3.369140625
▁pain 2.578125
▁relief 3.607421875
▁cent 0.984375
ers 0.0122833251953125
▁in 0.708984375
▁Israel 6.8125
. 0.34765625
▁All 3.474609375
▁patients 1.5126953125
▁experienced 4.375
▁chron 0.8857421875
ic 0.00022351741790771484
▁pain 0.16650390625
▁for 2.177734375
▁at 0.66015625
▁least 0.00202178955078125
▁ 1.5771484375
3 1.53125
▁months 0.35009765625
. 1.2431640625
▁The 1.4228515625
▁study 2.57421875
▁included 1.6005859375
▁ 0.6416015625
8 2.978515625
9 2.630859375
0 3.345703125
▁participants 1.96875
, 1.5302734375
▁of 2.978515625
▁which 0.36572265625
▁ 0.11273193359375
4 1.09375
7 2.619140625
4 2.60546875
▁( 3.1171875
5 0.10247802734375
9 4.9375
%) 0.54736328125
▁were 0.9248046875
▁treated 3.154296875
▁sole 6.42578125
ly 0.00019729137420654297
▁with 0.360107421875
▁op 1.2763671875
io 0.358642578125
ids 0.13916015625
, 0.61279296875
▁ 1.0673828125
3 1.1953125
2 2.23046875
9 2.4765625
▁( 0.0548095703125
4 2.44921875
1 1.125
%) 0.043487548828125
▁were 1.6376953125
▁treated 0.66259765625
▁with 0.280517578125
▁MM 0.478271484375
, 0.544921875
▁and 0.122314453125
▁ 0.223388671875
7 1.923828125
7 2.59765625
▁( 0.1248779296875
8 1.7373046875
. 1.02734375
6 2.154296875
%) 0.0670166015625
▁acquired 10.265625
▁both 0.54052734375
▁( 5.0234375
Fe 8.8125
ing 1.6806640625
old 0.342041015625
▁et 1.09375
▁al 0.0237274169921875
., 0.16455078125
▁ 0.01355743408203125
2 0.018310546875
0 0.00030231475830078125
1 0.2095947265625
7 1.681640625
). 0.07208251953125
▁The 1.4482421875
▁remaining 7.26171875
▁ten 6.72265625
▁participants 1.46484375
▁who 4.875
▁did 2.353515625
▁not 0.006664276123046875
▁receive 2.208984375
▁ph 4.12109375
arma 0.10833740234375
ce 0.0013942718505859375
ut 2.0265579223632812e-06
ical 0.003204345703125
▁op 1.7890625
io 0.09527587890625
ids 0.0254058837890625
▁and 2.359375
▁medical 2.078125
▁mar 0.052825927734375
iju 0.0003552436828613281
ana 8.630752563476562e-05
▁were 0.421142578125
▁with 6.76171875
dra 0.0472412109375
wn 4.649162292480469e-06
▁from 0.2296142578125
▁the 0.18310546875
▁analysis 2.181640625
▁in 4.859375
▁the 1.4970703125
▁research 4.62890625
. 1.2236328125
▁Therefore 5.40625
, 0.01221466064453125
▁it 4.078125
▁is 1.119140625
▁not 2.91796875
▁possible 0.63330078125
▁to 0.00489044189453125
▁compreh 6.125
ens 0.1390380859375
ively 0.0172119140625
▁compare 1.1572265625
▁patients 4.6875
▁taking 3.79296875
▁medic 4.4609375
ations 0.71826171875
▁with 1.455078125
▁those 1.0263671875
▁who 0.74267578125
▁do 1.396484375
▁not 0.00421905517578125
. 0.5234375
<0x0A> 0.67431640625
The 0.79736328125
▁study 2.349609375
▁looked 6.96875
▁at 0.47900390625
▁the 0.87109375
▁inter 7.25
dep 3.16796875
end 0.0002715587615966797
ence 0.005802154541015625
▁of 0.68359375
▁factors 4.95703125
▁that 1.6259765625
▁affect 2.1015625
▁the 0.9619140625
▁physical 5.25
▁and 0.3544921875
▁emot 0.56494140625
ional 0.00013446807861328125
▁condition 1.3857421875
▁of 0.10498046875
▁patients 0.716796875
. 0.80517578125
<0x0A> 2.59375
The 0.89453125
▁question 4.421875
na 1.1337890625
ires 6.020069122314453e-05
▁used 2.52734375
▁different 7.30859375
▁variable 9.8671875
▁measures 3.873046875
▁to 1.458984375
▁collect 3.271484375
▁information 1.650390625
. 1.3291015625
▁For 3.154296875
▁example 0.454833984375
, 0.00664520263671875
▁it 4.48046875
▁included 1.548828125
▁compreh 8.515625
ensive 0.0372314453125
▁so 5.83984375
cio 0.0023136138916015625
- 0.266357421875
dem 0.1246337890625
ographic 0.0638427734375
▁data 0.87890625
: 4.80859375
▁gender 1.908203125
, 0.054473876953125
▁age 0.2174072265625
, 0.026123046875
▁country 4.33203125
, 2.451171875
▁type 4.05859375
▁of 0.0980224609375
▁residence 4.29296875
▁( 2.1328125
urban 0.689453125
/ 1.380859375
r 0.1717529296875
ural 0.0011491775512695312
), 0.2325439453125
▁years 5.890625
▁of 0.166015625
▁education 0.7421875
, 0.125244140625
▁and 1.453125
▁employ 2.322265625
ment 0.00189971923828125
▁status 0.77197265625
. 0.19091796875
▁Pat 4.609375
ients 0.115234375
▁were 0.9423828125
▁also 0.7919921875
▁asked 0.41845703125
▁about 1.0439453125
▁their 0.73876953125
▁medical 2.548828125
▁history 0.406005859375
▁over 8.421875
▁the 0.07012939453125
▁years 4.35546875
▁and 1.736328125
▁the 1.3671875
▁current 2.921875
▁presence 5.265625
▁of 0.076904296875
▁any 2.201171875
▁severe 3.623046875
▁dise 1.7822265625
ases 6.628036499023438e-05
▁such 4.29296875
▁as 0.0011959075927734375
▁heart 2.75390625
▁failure 1.6982421875
, 0.3349609375
▁di 1.5810546875
ab 0.0007953643798828125
etes 0.002376556396484375
, 0.073486328125
▁ar 4.171875
th 0.185302734375
rit 0.0243682861328125
is 0.0044708251953125
, 0.03436279296875
▁and 1.3232421875
▁so 2.23828125
▁on 0.140380859375
. 0.061920166015625
▁The 1.62109375
▁third 6.1953125
▁measure 3.943359375
▁of 2.171875
▁the 0.91845703125
▁question 1.845703125
naire 0.1651611328125
▁was 1.1181640625
▁indicated 11.1015625
▁by 1.109375
▁information 7.0625
▁on 1.9580078125
▁any 5.49609375
▁twelve 14.2265625
- 0.2467041015625
month 0.189453125
▁and 4.92578125
▁lifetime 0.896484375
▁drug 3.49609375
▁and 1.6015625
▁alco 0.1383056640625
hol 6.079673767089844e-05
▁consumption 4.5078125
. 0.45068359375
▁In 3.6953125
▁addition 0.708984375
, 0.235595703125
▁the 0.9033203125
▁record 9.7734375
▁included 1.3056640625
▁a 2.537109375
▁pain 4.10546875
▁measurement 4.78125
▁scale 0.7685546875
▁from 4.3203125
▁ 0.50146484375
0 0.341796875
▁to 0.2279052734375
▁ 0.0050201416015625
1 0.0665283203125
0 0.0269927978515625
▁to 3.884765625
▁evaluate 2.369140625
▁dis 5.83984375
com 0.0751953125
fort 0.0006489753723144531
▁feelings 8.125
▁during 4.16015625
▁the 0.247314453125
▁last 1.0029296875
▁month 1.822265625
. 0.28564453125
<0x0A> 0.8935546875
Am 6.26953125
ong 0.00931549072265625
▁all 2.47265625
▁participants 2.263671875
▁in 4.0078125
▁the 0.12457275390625
▁study 0.410400390625
, 0.0374755859375
▁ 0.78076171875
4 1.8779296875
2 2.294921875
. 1.228515625
2 2.24609375
% 0.056915283203125
▁suffered 3.841796875
▁from 0.0596923828125
▁de 1.5419921875
pression 0.11798095703125
, 0.85791015625
▁and 1.326171875
▁ 0.10528564453125
3 1.2861328125
7 2.283203125
% 2.5234375
▁experienced 2.107421875
▁excess 7.47265625
ive 0.0322265625
▁anx 0.247314453125
iety 0.0007715225219726562
. 0.43896484375
▁The 1.564453125
▁pl 11.1015625
ur 0.6396484375
ality 0.0006895065307617188
▁of 0.1456298828125
▁de 2.642578125
press 1.423828125
ive 0.032745361328125
▁dis 3.14453125
orders 0.1280517578125
▁among 3.138671875
▁patients 0.76025390625
▁in 4.24609375
▁the 1.2099609375
▁op 3.181640625
i 3.087890625
ates 0.0268402099609375
, 8.1015625
▁medical 2.9921875
▁mar 0.03741455078125
iju 0.0009517669677734375
ana 2.5987625122070312e-05
, 0.27783203125
▁and 0.070556640625
▁mixed 1.89453125
▁OP 11.6640625
MM 4.01953125
▁groups 0.90380859375
▁number 8.9140625
ed 0.0220184326171875
▁ 0.1651611328125
5 2.1640625
7 2.79296875
. 0.55224609375
1 2.541015625
%, 0.248046875
▁ 0.00466156005859375
2 3.111328125
2 2.8125
. 0.1168212890625
3 2.26171875
%, 0.057342529296875
▁and 0.0550537109375
▁ 0.002017974853515625
5 2.041015625
1 2.0625
. 0.1612548828125
4 1.8173828125
%, 0.16162109375
▁respectively 0.0233154296875
. 0.257080078125
▁The 1.2373046875
▁pl 3.880859375
ur 0.0114898681640625
ality 3.063678741455078e-05
▁of 0.0311431884765625
▁anx 0.417236328125
iety 0.0223388671875
▁contained 10.078125
▁ 0.25048828125
4 1.146484375
8 2.369140625
. 0.1707763671875
4 2.19921875
% 1.9814453125
▁among 2.73828125
▁OP 4.0390625
▁patients 6.5859375
, 0.205078125
▁ 0.06573486328125
2 0.99658203125
1 2.48828125
. 0.1119384765625
5 2.099609375
% 0.025634765625
▁among 0.416259765625
▁MM 0.11151123046875
▁patients 0.460693359375
, 0.0237274169921875
▁and 0.0143890380859375
▁ 0.026641845703125
3 1.37890625
8 1.884765625
. 0.12091064453125
7 2.216796875
% 0.010833740234375
▁among 0.2122802734375
▁OP 1.7392578125
MM 0.12078857421875
▁participants 3.126953125
. 0.2398681640625
▁Pat 5.10546875
ients 0.0227813720703125
▁who 1.4921875
▁took 2.369140625
▁strong 9.3359375
▁op 0.9462890625
i 0.861328125
ates 0.0034198760986328125
▁were 1.8984375
▁t 9.7421875
ended 0.90234375
▁to 0.0080413818359375
▁place 9.8984375
▁their 2.37109375
▁pain 1.390625
▁on 1.943359375
▁a 0.66748046875
▁scale 2.041015625
▁of 0.42236328125
▁ 0.11029052734375
9 2.71484375
▁to 2.453125
▁ 0.01103973388671875
1 0.00910186767578125
0 0.00778961181640625
▁( 2.509765625
Fe 2.046875
ing 0.00341033935546875
old 0.0004754066467285156
▁et 0.01560211181640625
▁al 0.0010118484497070312
., 0.01084136962890625
▁ 0.0011920928955078125
2 0.00028133392333984375
0 2.9087066650390625e-05
1 0.0012969970703125
7 0.006847381591796875
). 0.0154876708984375
▁They 4.171875
▁were 2.0078125
▁also 0.89697265625
▁an 9.1015625
gu 4.1328125
ished 0.07855224609375
▁em 5.55859375
otion 0.0004527568817138672
ally 0.000690460205078125
▁and 1.3408203125
▁react 7.21484375
ed 0.023651123046875
▁rad 9.28125
ically 0.0010776519775390625
▁neg 5.04296875
atively 0.0014562606811523438
▁to 0.169677734375
▁almost 5.35546875
▁all 1.5498046875
▁survey 3.9609375
▁questions 0.323486328125
. 0.346923828125
▁Pat 3.1640625
ients 0.00684356689453125
▁who 0.8955078125
▁took 1.697265625
▁only 4.20703125
▁MM 0.357666015625
▁or 2.955078125
▁mixed 2.416015625
▁medic 1.486328125
ations 0.2340087890625
▁course 13.8125
▁had 2.484375
▁a 1.423828125
▁significantly 2.86328125
▁more 3.1796875
▁stable 2.408203125
▁emot 0.88134765625
ional 0.0012683868408203125
▁state 0.62939453125
▁and 1.3037109375
▁cop 7.046875
ed 0.0276336669921875
▁with 0.369873046875
▁pain 0.82373046875
▁more 1.8720703125
▁manage 6.96484375
able 1.576171875
. 0.353515625
<0x0A> 0.51318359375
One 5.16015625
▁of 0.312744140625
▁the 0.00396728515625
▁major 3.005859375
▁limitations 2.73046875
▁is 2.79296875
▁the 0.47412109375
▁ins 4.66796875
u 0.0718994140625
fficient 0.04180908203125
ly 3.263671875
▁high 3.283203125
▁response 2.873046875
▁rate 0.1009521484375
, 2.771484375
▁ 4.0859375
5 1.7294921875
7 2.833984375
% 2.134765625
▁instead 6.0546875
▁of 0.00286865234375
▁ 0.5361328125
7 1.7763671875
0 0.450439453125
% 1.3427734375
▁( 2.26953125
Fe 0.70166015625
ing 0.0019512176513671875
old 0.0003254413604736328
▁et 0.00942230224609375
▁al 0.0003979206085205078
., 0.006931304931640625
▁ 0.0010395050048828125
2 0.00011682510375976562
0 7.855892181396484e-05
1 0.0004210472106933594
7 0.0038013458251953125
). 0.01410675048828125
▁It 2.212890625
▁can 3.146484375
▁be 0.6279296875
▁fairly 8.140625
▁explained 2.162109375
▁by 0.2015380859375
▁the 0.28173828125
▁weak 7.1953125
▁focus 6.74609375
▁of 0.7080078125
▁respond 5.40625
ents 0.136962890625
▁who 3.34765625
▁have 3.802734375
▁overcome 8.25
▁severe 2.0
▁pain 0.49609375
▁sens 7.3984375
ations 0.2342529296875
▁and 0.94482421875
▁de 4.9375
press 0.8662109375
ive 0.047271728515625
▁episodes 2.19921875
. 0.51025390625
▁It 2.890625
▁is 0.62451171875
▁not 2.5234375
▁clear 3.390625
▁how 1.8017578125
▁to 3.478515625
▁use 5.3125
▁these 2.76953125
▁statistics 4.3984375
, 3.169921875
▁as 1.37890625
▁they 1.9365234375
▁still 5.26953125
▁may 4.5078125
▁be 1.212890625
▁relevant 6.1484375
▁for 1.7236328125
▁the 1.7685546875
▁overall 4.55859375
▁analysis 3.0859375
. 0.810546875
